Analyst Coverage

Former Cochlear exec’s robot microbiologist is four times faster than a human

Andrew Ramadge from Stockhead interviews CEO and MD Brent Barnes and discusses the APAS Independence device including its history, how the device works and its most recent milestones on its path to market.

Read more

CEO Interviews: LBT Innovations brings AI to pathology labs – a healthcare investment worth a (pee)k

CEO and MD Brent Barnes is interviewed by Alan Kohler from The Constant Investor about LBT Innovations medical devices bringing Artificial Intelligence (AI) to pathology labs.

Read more

NAB Trade -- 4 Stocks under 50 cents

James Dunn gives his recommendations on LBT Innovations and a small collection of stocks under 50 cents.

Read more

Under the Radar Issue 250

Under the Radar is a small caps analyst report written by Richard Hemming and Tim Boreham. Original article appeared on www.undertheradarreport.com.au and has been reproduced with permission.

Download

LBT Innovations keen on cornerstone-type investor to help develop wound product - CEO

Article written by Acuris (formerly Merger Market) contributor Louise Weihart on our chronic wounds measurement product WoundVue.

Download

Bioshares No. 701 -- LBT Innovations

Bioshares delivers independent investment research to investors in Australian biotech, pharma and healthcare companies.

Download

Brent Barnes Interview with Tom Piotrowski on the Commsec Executive Series

Read more

Biotech Daily LBT-Apr-13-2017

Download

Bioshares No. 690 -- LBT Innovations

Bioshares delivers independent investment research to investors in Australian biotech, pharma and healthcare companies.

Download

Bioshares No. 669 -- LBT Innovations

Bioshares delivers independent investment research to investors in Australian biotech, pharma and healthcare companies.

Download